Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches

Bibliography

• Chaudhari MD, Sonawane RO, Zawar L, et al. Solubility and dissolution enhancement of poorly water soluble glimepiride by using solid dispersion technique. Int J Pharm Pharm Sci 2012;4:535-9
   Google Scholar
• Ammar HO, Salama HA, El-Nahhas SA, Elmotasem H. Design and evaluation of chitosan films for transdermal delivery of glimepiride. Curr Drug Deliv 2008;5:290-8
   PubMedGoogle Scholar
• Cho CW, Choi JS, Yang KH, Shin SC. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix. Drug Deliv 2009;16:320-30
   PubMed Web of Science ®Google Scholar
• Ball AM, Smith KM. Optimizing transdermal drug therapy. Am J Health Syst Pharm 2008;65:1337-46
   PubMed Web of Science ®Google Scholar
• Ah YC, Choi JK, Choi YK, et al. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm 2010;385:12-19
   PubMed Web of Science ®Google Scholar
• Akimoto T, Nagase Y. Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group. J Control Release 2003;88:243-52
   PubMed Web of Science ®Google Scholar
• Alexander A, Dwivedi S, Ajazuddin et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 2012;164:26-40
   PubMed Web of Science ®Google Scholar
• Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008;364:227-36
   PubMed Web of Science ®Google Scholar
• Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012;64:11-29
   PubMed Web of Science ®Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14
   PubMed Web of Science ®Google Scholar
• Singh B, Khurana L, Bandyopadhyay S, et al. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDs) of carvedilol with enhanced bioavailability potential. Drug Deliv 2011;18:599-612
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Singh HP, et al. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech 2012;13:1416-27
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 2007;329:166-72
   PubMed Web of Science ®Google Scholar
• Janga KY, Jukanti R, Sunkavalli S, et al. In situ absorption and relative bioavailability studies of zaleplon loaded self-nanoemulsifying powders. J Microencapsul 2013;30:161-72
   PubMed Web of Science ®Google Scholar
• Khan AW, Kotta S, Ansari SH, et al. Potentials and challenges in self-nanoemulsifying drug delivery systems. Expert Opin Drug Deliv 2012;9:1305-17
   PubMed Web of Science ®Google Scholar
• Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm 2009;380:133-41
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Ibrahim HM, Ibrahim F, et al. In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations. Pharm Dev Technol 2011;16:497-510
   PubMed Web of Science ®Google Scholar
• Singh B, Bandyopadhyay S, Kapil R, et al. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst 2009;26:427-521
   PubMed Web of Science ®Google Scholar
• Singh S, Singh J. Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med Res Rev 1993;13:569-621
   PubMed Web of Science ®Google Scholar
• Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173-82
   PubMed Web of Science ®Google Scholar
• Thomas N, Mullertz A, Graf A, Rades T. Influence of lipid composition and drug load on the In Vitro performance of self-nanoemulsifying drug delivery systems. J Pharm Sci 2012;101:1721-31
   PubMed Web of Science ®Google Scholar
• Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond) 2010;5:1595-616
   PubMed Web of Science ®Google Scholar
• Ahmed OAA, Badr-Eldin SM, Tawfik MK, et al. Design and optimization of self-nanoemulsifying delivery system to enhance quercetin hepatoprotective activity in paracetamol-induced hepatotoxicity. J Pharm Sci 2014;103:602-12
   PubMed Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 2010;391:203-11
   PubMed Web of Science ®Google Scholar
• Gao ZS, Wang L, Zhang M. Effects of penetration enhancers on curcumin transdermal drug delivery. Zhong Yao Cai 2012;35:141-4
   PubMedGoogle Scholar
• Li L, Fang L, Xu X, et al. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole. Biopharm Drug Dispos 2010;31:138-49
   PubMed Web of Science ®Google Scholar
• El-Enany NM, Abdelal AA, Belal FF, et al. Development and validation of a repharsed phase-HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma. Chem Cent J 2012;6:1-10
   PubMed Web of Science ®Google Scholar
• Vaddi HK, Ho PC, Chan SY. Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci 2002;91:1639-51
   PubMed Web of Science ®Google Scholar
• Ozsoy Y, Güngor S, Cevher E. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations. Farmaco 2004;59:563-6
   PubMedGoogle Scholar
• Donbrow M, Samuelov Y. Zero order drug delivery from double-layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures. J Pharm Pharmacol 1980;32:463-70
   PubMed Web of Science ®Google Scholar
• Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253-7
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Theoritical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35
   Web of Science ®Google Scholar
• Ladrière L, Malaisse-Lagae F, Fuhlendorff J, Malaisse WJ. Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats. Eur J Pharmacol 1997;335:227-34
   PubMed Web of Science ®Google Scholar
• Kim H, Chang KY, Lee HJ, Han SB. Determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. Bull Korean Chem Soc 2004;25:109-14
   Web of Science ®Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000;S2:S93-8
   Google Scholar
• Yener G, Üner M, Gonüllü Ü, et al. Design of meloxicam and lornoxicam transdermal patches: preparation, physical characterization, ex vivo and in vivo studies. Chem Pharm Bull (Tokyo) 2010;58:1466-73
   PubMed Web of Science ®Google Scholar
• Galani V, Vyas M. In vivo and in vitro drug interactions study of glimepride with atorvastatin and rosuvastatin. J Young Pharm 2010;2:196-200
   PubMedGoogle Scholar
• Yun HY, Park HC, Kang W, Kwon KI. Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans. J Clin Pharm Ther 2006;31:469-76
   PubMed Web of Science ®Google Scholar
• Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Del Rev 2002;54:S77-98
   PubMed Web of Science ®Google Scholar
• Villar AM, Naveros BC, Campmany AC, et al. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm 2012;431:161-75
   PubMed Web of Science ®Google Scholar
• Gao P, Witt MJ, Haskell RJ, et al. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm Dev Technol 2004;9:301-9
   PubMed Web of Science ®Google Scholar
• Ahmed OAA, Badr-Eldin SM, Ahmed TA. Kinetic study of the in vitro release and stability of theophylline floating beads. Int J Pharm Pharm Sci 2013;5:179-84
   Google Scholar
• Cox PJ, Khan KA, Munday DL, Sujja-areevath J. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics. Int J Pharm 1999;193:73-84
   PubMed Web of Science ®Google Scholar
• Harland RS, Gazzaniga A, Sangalli ME, Colombo P. Drug/polymer matrix swelling and dissolution. Pharm Res 1988;5:488-94
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48:139-57
   PubMed Web of Science ®Google Scholar